Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Gyllensten Science Consulting AB
AB
Active
Org 5593809436
Malma Backe 7 H
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 810K
-8% vs 2023
EBITDA margin
98.9%
-6% vs 2023
Equity ratio
73.9%
Financial strength
Net profit 2024
SEK 646K
-5% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2022
1M
+100%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 810K
-8%
EBITDA
SEK 801K
-6%
Net profit
SEK 646K
-5%
Total assets
SEK 1,8M
+57%
Equity
SEK 1,3M
+52%
Employees
0
—
Company information
Legal name
Gyllensten Science Consulting AB
Org number
5593809436
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 maj 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom biomedicin och media.
Contact
Address
Malma Backe 7 H
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
473
878
810
Staff expenses
—
—
—
EBITDA
447
852
801
Depreciation & amort.
—
—
—
EBIT
447
852
801
Net financials
1
6
13
Profit before tax
448
859
814
Tax
−93
−177
−168
Net profit
355
682
646
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
568
1 139
1 784
Equity
380
867
1 319
Long-term debt
—
—
—
Short-term debt
187
272
466
Total debt
187
272
466
Financial ratios
5-year trend
EBITDA margin
98.9%
This company
15.8%
Market median
+526% vs market
2022
2024
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
2022
2024
Return on equity
49.0%
This company
18.4%
Market median
+166% vs market
2022
2024
Net profit margin
79.8%
This company
8.1%
Market median
+885% vs market
2022
2024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
2022
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-05-16 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
UB
Ulf Bertil Gyllensten
Board of Directors
2022
IE
Ines Ezcurra
Deputy Board Member
2022
Former (3)
LH
Lars Hugo Viking Rillner
Deputy Board Member
2022 – 2022
SM
Stina Maria Selldén
Deputy Board Member
2022 – 2022
MJ
Mikaela Jenni Berglund
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Gyllensten Science Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ulf Bertil Gyllensten
Board of Directors
0 companies
Ines Ezcurra
Deputy Board Member
0 companies
Lars Hugo Viking Rillner
Deputy Board Member
0 companies
Stina Maria Selldén
Deputy Board Member
0 companies
Mikaela Jenni Berglund
Board of Directors
0 companies